Literature DB >> 24623069

Measuring adherence by visual inspection of returned empty gel applicators in the CAPRISA 004 microbicide trial.

Tanuja N Gengiah1, Leila E Mansoor, Michele Upfold, Anushka Naidoo, Nonhlanhla Yende-Zuma, Angela D M Kashuba, Quarraisha Abdool Karim, Salim S Abdool Karim.   

Abstract

In the CAPRISA 004 trial, adherence was estimated as the proportion of reported sex acts covered by two gel doses, which was assessed by counting returned empty gel applicators. The returned empty applicators were inspected visually in a standardized manner for residue on the outside of the applicator, as an indicator of vaginal insertion. Over 15 months, spanning 11,839 study visits by 838 women, a total of 59,800 returned empty applicators were inspected. By visual assessment, 77.5 % of these applicators appeared to have been inserted. To test the accuracy of the assessment we fitted a Cox model and found that the risk for HIV infection was doubled when less than half of the returned empty applicators had been assessed as not inserted in the vagina. Visual inspection enhanced both the accuracy of the adherence measurement and aided identification of mechanical problems with applicator use experienced by women in the trial.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24623069      PMCID: PMC4036812          DOI: 10.1007/s10461-014-0749-4

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  16 in total

Review 1.  Weighing the gold in the gold standard: challenges in HIV prevention research.

Authors:  Nancy S Padian; Sandra I McCoy; Jennifer E Balkus; Judith N Wasserheit
Journal:  AIDS       Date:  2010-03-13       Impact factor: 4.177

Review 2.  Modeling and simulation of adherence: approaches and applications in therapeutics.

Authors:  Leslie A Kenna; Line Labbé; Jeffrey S Barrett; Marc Pfister
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

Review 3.  Practical and conceptual challenges in measuring antiretroviral adherence.

Authors:  Karina M Berg; Julia H Arnsten
Journal:  J Acquir Immune Defic Syndr       Date:  2006-12-01       Impact factor: 3.731

4.  Assessment of adherence to product dosing in a pilot microbicide study.

Authors:  Kathleen Hogarty; Andrea Kasowitz; Betsy C Herold; Marla J Keller
Journal:  Sex Transm Dis       Date:  2007-12       Impact factor: 2.830

5.  Discrepancies between self-report and objective measures for stimulant drug use in HIV: cognitive, medication adherence and psychological correlates.

Authors:  M J Reinhard; C H Hinkin; T R Barclay; A J Levine; S Marion; S A Castellon; D Longshore; T Newton; R S Durvasula; M N Lam; H Myers
Journal:  Addict Behav       Date:  2007-04-14       Impact factor: 3.913

Review 6.  Adherence to preexposure chemoprophylaxis: the behavioral bridge from efficacy to effectiveness.

Authors:  K Rivet Amico
Journal:  Curr Opin HIV AIDS       Date:  2012-11       Impact factor: 4.283

7.  Acceptability and feasibility of Micralax applicators and of methyl cellulose gel placebo for large-scale clinical trials of vaginal microbicides.

Authors:  N Coetzee; K Blanchard; C Ellertson; A A Hoosen; B Friedland
Journal:  AIDS       Date:  2001-09-28       Impact factor: 4.177

8.  Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial.

Authors:  Stephanie Skoler-Karpoff; Gita Ramjee; Khatija Ahmed; Lydia Altini; Marlena Gehret Plagianos; Barbara Friedland; Sumen Govender; Alana De Kock; Nazira Cassim; Thesla Palanee; Gregory Dozier; Robin Maguire; Pekka Lahteenmaki
Journal:  Lancet       Date:  2008-12-06       Impact factor: 79.321

9.  Determining the feasibility of utilizing the microbicide applicator compliance assay for use in clinical trials.

Authors:  Andrea R Wallace; Aaron Teitelbaum; Livia Wan; Maria Gloria Mulima; Laura Guichard; Stephanie Skoler; Stephanie Skiler; Hlengiwe Vilakazi; Fridda S Mapula; Jasmine Rossier; Sumen N Govender; Pekka Lahteenmaki; Robin A Maguire; David M Phillips
Journal:  Contraception       Date:  2007-05-11       Impact factor: 3.375

10.  Limitations of the dye-based method for determining vaginal applicator use in microbicide trials.

Authors:  Michele N Austin; Lorna K Rabe; Sharon L Hillier
Journal:  Sex Transm Dis       Date:  2009-06       Impact factor: 2.830

View more
  2 in total

1.  Divergent adherence estimates with pharmacokinetic and behavioural measures in the MTN-003 (VOICE) study.

Authors:  Ariane van der Straten; Elizabeth R Brown; Jeanne M Marrazzo; Michael Z Chirenje; Karen Liu; Kailazarid Gomez; Mark A Marzinke; Jeanna M Piper; Craig W Hendrix
Journal:  J Int AIDS Soc       Date:  2016-02-04       Impact factor: 5.396

2.  Rhodanine derivatives as potent anti-HIV and anti-HSV microbicides.

Authors:  Cristina Tintori; Giulia Iovenitti; Elisa Rita Ceresola; Roberto Ferrarese; Claudio Zamperini; Annalaura Brai; Giulio Poli; Elena Dreassi; Valeria Cagno; David Lembo; Filippo Canducci; Maurizio Botta
Journal:  PLoS One       Date:  2018-06-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.